đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
The new formulation administered as a 4th consecutive dose will be compared...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-14
Trial ID
NCT00611559
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety and react...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-14
Trial ID
NCT01453998
Treatments Being Tested
This phase 3b study will compare the immunogenicity and reactogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871000
Treatments Being Tested
The purpose of this trial is to evaluate the immunogenicity and safety of a...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04-01
Trial ID
NCT00652951
The study was designed to compare the safety and immunogenicity of DTap-IPV...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01346293
Treatments Being Tested
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The aims of this study are to compare the immunogenicity and safety of the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2002-11
Trial ID
NCT00263692
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335